InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

20 October 2025

Name:	MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED (MVP)
ISIN:	AU000000MVP2
Date of Listing:	15 December 2003

Stock Exchange Status: (updated daily)

This entity is currently listed and quoted on the Australian Securities Exchange.

Legal Status: (updated monthly)

ACN: 106 340 667ABN: 14 106 340 667
Registration Date: 16 September 2003

This is a current registered entity, not in any form of external administration to our knowledge.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED(MVP)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of MVP:

(4 out of 5)

COMPANY WEBSITE:

MVP website

MVP email

MVP investorRelations

MVP annualreports

MVP directors

REGISTRY:

Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000MVP2

Address: Suite 7, 56 Smith Road, SPRINGVALE, VIC, AUSTRALIA, 3171
Tel: (03) 9547 1888 Fax: (03) 9547 0262

Date first listed: 15/12/2003
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Designs, manufactures and distributes a wide range of equipment, products and devices in the anaesthetics, oxygen delivery, veterinary and asthma management fields - also manufactures a pre-hospital and emergency pain relief product which is widely used i

News & Events

Expand this box to read and print

The suspension of trading in the options of Medical Developments International will be lifted immediately.	02/09/2022
The company releases the Table of Top 20 Option Holders and Spread of Option Holders.	01/09/2022
The company releases a notice of application for quotation of securities.	31/08/2022
The company has successfully completed the retail component of the fully underwritten 1 for 9.5 pro rata accelerated non-renounceable entitlement offer of new fully paid shares in MVP together with 1 option for every 2.5 new shares issued under the entitlement offer.	30/08/2022
The options of Medical Developments International Limited will be suspended immediately in accordance with Listing Rule 17.3, as there will be no deferred settlement trading. The options are expected to be quoted on a normal settlement basis on Friday, 2 September 2022. The suspension only applies to MVP's options, and does not apply to any other quoted securities of MVP.	26/08/2022
listed entity carried for record purposes only	01/07/2004

OFX Transferring Money Internationally to Free

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
30/09/2025	Mark Fladrich	62,858	$0.710	$44,629.00
22/09/2025	Paul Townsend	25,000	$0.671	$16,785.00
03/04/2024	Russell Basser	15,873	$0.615	$9,762.00
07/09/2023	Gordon Naylor	56,000	$0.885	$49,560.00
26/11/2021	Gordon Naylor	62,000	$4.940	$306,280.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Gordon Naylor	Non Exec Chairman	14/10/2020
Brent MacGregor	CEO	01/11/2020
Anita James	CFO	27/05/2022
Leon Hoare	Non Exec Director	27/09/2013
Christine Emmanuel	Non Exec Director	26/05/2020
Mark Fladrich	Director	01/04/2025
Paul Townsend	Director	30/05/2025
Russell Basser	Director	01/09/2023
Tara Eaton	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.